Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
BIOX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
+375%
0.44
vs -0.16
Q2.23
N/A
-0.06
vs -0.08
Q3.23
N/A
-0.07
vs -0.12
Q4.23
+114%
0.02
vs -0.14
Q1.24
-68%
0.14
vs 0.44
Q2.24
N/A
-0.03
vs -0.06
Q3.24
N/A
-0.09
vs -0.07
Q4.24
-50%
0.01
vs 0.02
Q1.25
N/A
-0.13
vs 0.14
Q2.25
+525%
0.13
vs -0.03
Sales Growth
YoY
Current
Estimates
Q1.23
+36%
93M vs 68.2M
Q2.23
+3%
105.1M vs 101.6M
Q3.23
-8%
116.2M vs 126.8M
Q4.23
+48%
140.3M vs 94.5M
Q1.24
-10%
84M vs 93M
Q2.24
+18%
124.3M vs 105.1M
Q3.24
-20%
92.6M vs 116.2M
Q4.24
-24%
106.8M vs 140.3M
Q1.25
-25%
63M vs 84M
Q2.25
-4%
119.4M vs 124.3M
Return on Equity
QoQ
Q1.23
+9%
0.09
vs -0.03
Q2.23
-1%
-0.01
vs 0.09
Q3.23
-2%
-0.02
vs -0.01
Q4.23
+0%
0
vs -0.02
Q1.24
+3%
0.03
vs 0
Q2.24
0%
-0.00
vs 0.03
Q3.24
-2%
-0.02
vs -0.00
Q4.24
+0%
0
vs -0.02
Institutionnal Ownership
QoQ
Q1.23
50
50
vs 55
-9%
Q2.23
50
50
vs 50
NA
Q3.23
54
54
vs 50
8%
Q4.23
55
55
vs 54
2%
Q1.24
55
55
vs 55
NA
Q2.24
51
51
vs 55
-7%
Q3.24
50
50
vs 51
-2%
Q4.24
46
46
vs 50
-8%
accessnewswire.com
7 hours ago
accessnewswire.com
7 hours ago
seekingalpha.com
11 hours ago
seekingalpha.com
13 hours ago
businesswire.com
16 hours ago
Quote Panel
Key Metrics
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
0.00(-100.00%)
Number of analyst
0
Last analyst upgrade/downgrade
Canaccord Genuity
initialisePrevious: Not converted
2022-09-30
Now: Buy
Relative Strength
BIOX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How BIOX compares to sector?